Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Oriola

1.01 EUR

+1.00 %

7,755 following
Corporate customer

ORIOLA

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+1.00 %
-12.15 %
-12.00 %
-6.99 %
-12.76 %
-10.12 %
-35.13 %
-49.53 %
-44.98 %

Oriola is a pharmaceutical group with a particular focus on the distribution of pharmaceuticals to other players in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest operations are in the Nordic and Baltic regions. The headquarters are located in Espoo.

Read more
Market cap
187.55M EUR
Turnover
137.9K EUR
P/E (adj.) (26e)
12.29
EV/EBIT (adj.) (26e)
1.74
P/B (26e)
1.8
EV/S (26e)
0.02
Dividend yield-% (26e)
3.95 %
Coverage
Recommendation
Accumulate
Target price
1.20 EUR
Updated
2026-02-25
Disclaimer
Rauli Juva
Rauli Juva

Analyst

Latest research

Latest analysis report

Released: 2026-01-14

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25/3
2026

General meeting '26

26/3
2026

Annual dividend

29/4
2026

Interim report Q1'26

Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Oriola: Balansräkningen behöver mer eget kapital
Analyst Comment13 hours ago by
Rauli Juva

Oriola: Balansräkningen behöver mer eget kapital

I denna översikt går vi igenom Oriolas balansräkning.

Oriola
Regulatory press release3/4/2026, 8:00 AM

Oriola Oyj: Oriola's Annual Report 2025 published

Oriola
Third party research2/26/2026, 8:34 AM

Oriola: Awaiting news on strategy review - Evli

Oriola’s Q4 was overall rather good, with double-digit growth exceeding expectations while profitability in Wholesale remained soft. For now, all eyes are on news from the strategy review and Capital Markets Day in May.

Oriola

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/25/2026, 10:00 AM

Oriola Oyj: Notice to Oriola Corporation's Annual General Meeting 2026

Oriola
Oriola, Webcast, Q4'25
Webcast2/25/2026, 8:00 AM

Oriola, Webcast, Q4'25

Oriola
Oriola Q4’25 snabbkommentar: Egen verksamhet i stort sett enligt förväntningarna, stor förlust från Kronans
Analyst Comment2/25/2026, 7:15 AM by
Rauli Juva

Oriola Q4’25 snabbkommentar: Egen verksamhet i stort sett enligt förväntningarna, stor förlust från Kronans

Oriolas resultat från den egna verksamheten var ungefär som vi förväntade oss och guidningen om en resultatförbättring för i år var väntad.

Oriola
Third party research2/25/2026, 7:12 AM

Oriola: Growth pace remains solid - Evli

Oriola posted overall good figures in Q4. Net sales and invoicing growth was in the double-digits, and the pace exceeded our expectations. The adj. EBITDA of EUR 9.9m fell slightly short of our EUR 10.3m expectations, as the profitability in the Wholesale...

Oriola
Regulatory press release2/25/2026, 6:30 AM

Oriola Oyj: Oriola Corporation's Financial Statements Release 1 January-31 December 2025

Oriola
Third party research2/23/2026, 7:49 AM

Oriola: Expecting a busy year ahead - Evli

We expect continued good growth in Q4 and fairly flat margin development q/q. 2026 is looking to be a busy year, but if one should be excited about the actions to be taken still remains to be seen.

Oriola
Oriola Q4'25 förhandskommentar: Vinsttillväxt i receptet, men utdelningen måste bantas
Analyst Comment2/23/2026, 5:40 AM by
Rauli Juva

Oriola Q4'25 förhandskommentar: Vinsttillväxt i receptet, men utdelningen måste bantas

Vi estimerar att utdelningen sänks till 0,04 euro för att stärka balansräkningen – en svag balansräkning kan till och med kräva en nyemission.

Oriola
Press release2/11/2026, 7:00 AM

Oriola Oyj: Oriola Corporation to publish its Financial Statements Release 2025 on 25 February 2026

Oriola
Article1/31/2026, 8:00 AM by
Daniel Vähä-Antila

Utdelningsutsikter 2026: börsens direktavkastning minskar

Helsingforsbörsens direktavkastning förväntas minska från jämförelseperioden. Utdelningssänkningar är att vänta, men hög direktavkastning finns också tillgänglig från utvalda företag.

MandatumFortumNordea BankVerkkokauppa.comArvo SijoitusosuuskuntaTerveystaloPihlajalinnaMetsä BoardOriolaFiskarsTitaniumStora EnsoUPM-Kymmene
Regulatory press release1/15/2026, 8:00 AM

Oriola Oyj: Proposals of the Shareholders' Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2026 Annual General Meeting

Oriola
Oriola: Vi tror att balansräkningsarrangemangen närmar sig
Research1/14/2026, 6:00 AM by
Rauli Juva

Oriola: Vi tror att balansräkningsarrangemangen närmar sig

Vi tror att Oriola kommer att meddela planer på att sälja sitt ägande i Kronans Apotek och stärka företagets soliditet under vårens kapitalmarknadsdag.

Oriola
Oriola presenterade investeringsplanen för distributionscentret och belyste nyckelteman i den nya strategin
Analyst Comment1/8/2026, 6:34 AM by
Arttu Heikura

Oriola presenterade investeringsplanen för distributionscentret och belyste nyckelteman i den nya strategin

Huvudsyftet med investeringen är att förbättra Oriolas produktivitet och säkerställa ytterligare kapacitet för framtida tillväxt.

Oriola
Regulatory press release1/7/2026, 10:35 AM

Oriola Oyj: Inside information: Oriola accelerates growth and modernises Finnish operations with a highly automated, state-of-the-art distribution centre in Järvenpää

Oriola
Press release1/7/2026, 10:30 AM

Oriola Oyj: Oriola initiates review of long-term plan, financial targets and capital allocation priorities - Capital Markets Day scheduled

Oriola
Oriola: Nedskrivning av joint venture-bolaget Kronans värde, likt förra året
Analyst Comment12/19/2025, 11:25 AM by
Rauli Juva

Oriola: Nedskrivning av joint venture-bolaget Kronans värde, likt förra året

Nedskrivningen tynger Oriolas rapporterade resultat med 16 MEUR under resten av året, men påverkar inte kassaflödet eller justerade siffror.

Oriola
Regulatory press release12/19/2025, 11:00 AM

Oriola Oyj: Kronans Apotek to record an impairment with an impact of approximately EUR 16 million to Oriola's net result

Oriola
Press release12/15/2025, 11:00 AM

Oriola Oyj: Change negotiations in connection with Oriola's plan for a new distribution centre in Finland have been concluded

Oriola
Forum discussions
NOT LIKE THIS! That was some tough reading, as the whole report was pure bullshit bingo. The dividend was halved, and Kronans is still a complete farce. The ERP project apparently takes forever and has failed completely; AI was also mentioned in the report, because well, I don’t ...
2/25/2026, 9:06 AM
by Trivial
17
This post is primarily intended for Oriola’s communications and finance departments as a comment for improving Oriola’s financial reporting and for the Capital Markets Day. The biggest problem with Oriola’s financial reporting is that true and fair information regarding the JV company...
1/19/2026, 2:10 PM
by Aktivisti26
17
Inderes Oriola Oyj:n tilinpäätöstiedote 1.1.- 31.12.2025 - Inderes Oriola Oyj:n pörssitiedote 25.2.2026 klo 8.30Oriola Oyj:n tilinpäätöstiedote 1.1.- 31.12.2025Oikaistun käyttökatteen ja strategisten tavoitteiden vakaa kehitysLoka-joulukuun 2025 pääkohdat Laskutus... October–December...
2/25/2026, 6:34 AM
by kimsku
10
Iikka interviewed Oriola’s CEO Katarina Gabrielson regarding the Q4 results Inderes Oriola Q4'25: Double‑digit revenue growth - Inderes Aika: 25.02.2026 klo 14.26 Oriola’s revenue grew 14% in Q4. Oriola’s adjusted EBITDA improved to 9.9 MEUR from 9.4 MEUR in the comparison period...
2/25/2026, 3:02 PM
by Sijoittaja-alokas
7
The bot interpreted this somewhat confusing reporting quite well, but here’s my quick comment as well Inderes Oriola Q4’25 -pikakommentti: Omat toiminnot karkeasti odotuksiin, Kronansista... Oriolan omien toimintojen tulos osui suunnilleen odotuksiimme ja ohjeistus tulosparannuksesta...
2/25/2026, 7:32 AM
by Rauli_Juva
7
Of course the ERP isn’t ready yet, as it was stated at the beginning of 2024 that the project would last until 2027. However, it was mentioned on the call that it hasn’t been decided yet whether the old system will be used first in the new distribution center to be built in Finland...
2/25/2026, 10:22 AM
by Rauli_Juva
6
I looked into Oriola’s situation further with Rauli on video. A relatively complex situation with many variables. Inderes Oriola: Käänneyhtiö tai arvoansa… - Inderes Aika: 10.03.2026 klo 12.53 Kassassa käteistä, taseessa ilmaa. Personally, I think I’ll just watch this one from the...
7 hours ago
by Verneri Pulkkinen
4
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.